Editing Serimmune antibody analysis results
Jump to navigation
Jump to search
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 1: | Line 1: | ||
− | |||
− | |||
[[File:Serimmunetypicalresults.png|alt=image of a sample result|thumb|Serimmune antibody test results sample.]] | [[File:Serimmunetypicalresults.png|alt=image of a sample result|thumb|Serimmune antibody test results sample.]] | ||
The [https://serimmune.com/covid19study/ Serimmune COVID-19 Study] is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure. | The [https://serimmune.com/covid19study/ Serimmune COVID-19 Study] is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure. | ||
− | |||
The study returns research-grade results (not intended for diagnostic clinical use) to participants. As described in the [https://serimmune.com/caspio-content/COVID-19-Study-Consent-Form-and-Bill-of-Rights-Preview.pdf study consent document], these results are not clinically validated and not meant to serve as a clinical assay. They are, nevertheless, interesting to look at! | The study returns research-grade results (not intended for diagnostic clinical use) to participants. As described in the [https://serimmune.com/caspio-content/COVID-19-Study-Consent-Form-and-Bill-of-Rights-Preview.pdf study consent document], these results are not clinically validated and not meant to serve as a clinical assay. They are, nevertheless, interesting to look at! | ||
Line 9: | Line 6: | ||
The study is planned to last five years, with blood samples collected every six months. Samples are self-collected by participants using a home collection kit and sent by mail. | The study is planned to last five years, with blood samples collected every six months. Samples are self-collected by participants using a home collection kit and sent by mail. | ||
− | = | + | {{Project Infobox|Self researchers=User:Madprime,User:Sprague |Related tools= |Related topics= }} |
+ | =SARS-CoV-2 Antibody Analyses= | ||
− | + | ==Vaccine-only responses== | |
− | + | {| class="wikitable" | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | {| class="wikitable | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
− | + | ! Individual !! Date !! Report !! Notes | |
|- | |- | ||
− | | [[User:Madprime]] || 2022- | + | | [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_20220203.pdf]] || Moderna vaccine (two shots, plus booster) |
|- | |- | ||
− | | [[User: | + | | [[User:Sprague]] || |2021-12-14 || [[File:RichardSpragueSerimmuneCOVID 20211214.pdf]] || Pfizer vaccine (two shots, no booster) |
− | |- | ||
− | |||
− | |||
− | |||
|} | |} | ||
+ | ==Post-exposure responses== | ||
+ | |||
+ | None yet; [[User:Madprime]] anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01). | ||
= Other results= | = Other results= | ||
Line 60: | Line 32: | ||
|- | |- | ||
!Individual!!Date!!Report!!Notes | !Individual!!Date!!Report!!Notes | ||
− | |||
− | |||
|- | |- | ||
| [[User:Madprime]]||2022-02-03||[[File:TOEAIX_Expanded_20220203.pdf]]||No medical history related to these analyses. | | [[User:Madprime]]||2022-02-03||[[File:TOEAIX_Expanded_20220203.pdf]]||No medical history related to these analyses. | ||
|- | |- | ||
− | | [[User: | + | | [[User:Sprague]] || 2022-12-14 || [[File:RichardSpragueSerimmune_20211214.pdf]] || |
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
− | + | {{Project Queries}} | |
[[Category:Projects]] | [[Category:Projects]] |